Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trial. (Q54086131)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trial. |
scientific article |
Statements
Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trial. (English)
Lalezari JP
Beal JA
Ruane PJ
Cohen CJ
Jacobson EL
Sundin D
Leong WP
Raffanti SP
Wheeler DA
Anderson RD
Keiser P
Schrader SR
Goodgame JC
Steinhart CR
Murphy RL
Wolin MJ
Smith KA
1 November 2000
1
3
1-15